108 related articles for article (PubMed ID: 2350886)
1. Prognosis in laryngeal carcinoma: host factors.
Stell PM
Clin Otolaryngol Allied Sci; 1990 Apr; 15(2):111-9. PubMed ID: 2350886
[TBL] [Abstract][Full Text] [Related]
2. Prognosis in laryngeal carcinoma: tumour factors.
Stell PM
Clin Otolaryngol Allied Sci; 1990 Feb; 15(1):69-81. PubMed ID: 2323084
[TBL] [Abstract][Full Text] [Related]
3. Prognosis in mouth cancer: host factors.
Stell PM
J Laryngol Otol; 1992 May; 106(5):399-402. PubMed ID: 1613364
[TBL] [Abstract][Full Text] [Related]
4. Glottic and supraglottic laryngeal carcinoma: differences in epidemiology, clinical characteristics and prognosis.
Raitiola H; Pukander J; Laippala P
Acta Otolaryngol; 1999; 119(7):847-51. PubMed ID: 10687946
[TBL] [Abstract][Full Text] [Related]
5. Impact of stage, management and recurrence on survival rates in laryngeal cancer.
Brandstorp-Boesen J; Sørum Falk R; Boysen M; Brøndbo K
PLoS One; 2017; 12(7):e0179371. PubMed ID: 28708883
[TBL] [Abstract][Full Text] [Related]
6. Tumour volume: implications in T2/T3 glottic/supraglottic squamous cell carcinoma.
Lo SM; Venkatesan V; Matthews TW; Rogers J
J Otolaryngol; 1998 Oct; 27(5):247-51. PubMed ID: 9800621
[TBL] [Abstract][Full Text] [Related]
7. [A clinical study of 1079 patients with laryngeal cancer].
Fujii T; Sato T; Yoshino K; Inakami K; Nagahara M; Okita J
Nihon Jibiinkoka Gakkai Kaiho; 1997 Aug; 100(8):856-63. PubMed ID: 9293766
[TBL] [Abstract][Full Text] [Related]
8. Squamous carcinoma of the head and neck: the untreated patient.
Stell PM; Morton RP; Singh SD
Clin Otolaryngol Allied Sci; 1983 Feb; 8(1):7-13. PubMed ID: 6831756
[TBL] [Abstract][Full Text] [Related]
9. Apoptosis in situ, p53, bcl-2 and AgNOR counts as prognostic factors in laryngeal carcinoma.
Pulkkinen JO; Klemi P; Martikainen P; Grénman R
Anticancer Res; 1999; 19(1B):703-7. PubMed ID: 10216480
[TBL] [Abstract][Full Text] [Related]
10. Radiotherapy for patients with early-stage glottic carcinoma: univariate and multivariate analyses in a group of consecutive, unselected patients.
Franchin G; Minatel E; Gobitti C; Talamini R; Vaccher E; Sartor G; Politi D; Trovò MG; Barzan L
Cancer; 2003 Aug; 98(4):765-72. PubMed ID: 12910521
[TBL] [Abstract][Full Text] [Related]
11. Retrospective analysis of 659 laryngeal squamous cell carcinoma patients treated with open laryngeal function-preserving operations.
Tang D; Tao L; Zhou L; Zhang M; Wu H; Li X; Chen X; Li C; Xie M; Cheng L
Acta Otolaryngol; 2018 Nov; 138(11):1043-1050. PubMed ID: 30776268
[TBL] [Abstract][Full Text] [Related]
12. Incidence of and survival after glottic squamous cell carcinoma in Denmark from 1971 to 2011-A report from the Danish Head and Neck Cancer Group.
Lyhne NM; Johansen J; Kristensen CA; Andersen E; Primdahl H; Andersen LJ; Oksbjerg S; Overgaard J
Eur J Cancer; 2016 May; 59():46-56. PubMed ID: 27014799
[TBL] [Abstract][Full Text] [Related]
13. Squamous cell carcinoma of the supraglottic larynx without clinically detectable lymph node metastases: problem of local relapse and influence of overall treatment time.
Hoekstra CJ; Levendag PC; van Putten WL
Int J Radiat Oncol Biol Phys; 1990 Jan; 18(1):13-21. PubMed ID: 2298616
[TBL] [Abstract][Full Text] [Related]
14. Recurrence after radiotherapy for glottic carcinoma.
Viani L; Stell PM; Dalby JE
Cancer; 1991 Feb; 67(3):577-84. PubMed ID: 1898708
[TBL] [Abstract][Full Text] [Related]
15. Delayed regional metastases, distant metastases, and second primary malignancies in squamous cell carcinomas of the larynx and hypopharynx.
Spector JG; Sessions DG; Haughey BH; Chao KS; Simpson J; El Mofty S; Perez CA
Laryngoscope; 2001 Jun; 111(6):1079-87. PubMed ID: 11404625
[TBL] [Abstract][Full Text] [Related]
16. Treatment results and prognostic factors of advanced T3--4 laryngeal carcinoma: the University of California, San Francisco (UCSF) and Stanford University Hospital (SUH) experience.
Nguyen-Tan PF; Le QT; Quivey JM; Singer M; Terris DJ; Goffinet DR; Fu KK
Int J Radiat Oncol Biol Phys; 2001 Aug; 50(5):1172-80. PubMed ID: 11483326
[TBL] [Abstract][Full Text] [Related]
17. Clinical and molecular prognostic factors in operable laryngeal cancer.
Vlachtsis K; Nikolaou A; Markou K; Fountzilas G; Daniilidis I
Eur Arch Otorhinolaryngol; 2005 Nov; 262(11):890-8. PubMed ID: 15739081
[TBL] [Abstract][Full Text] [Related]
18. Management of N0 neck in laryngeal carcinoma. Impact on patient's survival.
Pinilla M; González FM; López-Cortijo C; Arellano B; Herrero J; Trinidad A; Vergara J
J Laryngol Otol; 2003 Jan; 117(1):63-6. PubMed ID: 12590859
[TBL] [Abstract][Full Text] [Related]
19. Survival times in end-stage head and neck cancer.
Stell PM
Eur J Surg Oncol; 1989 Oct; 15(5):407-10. PubMed ID: 2792391
[TBL] [Abstract][Full Text] [Related]
20. [Clinical study of laryngeal cancer].
Higuchi E; Iizuka K; Shouda H; Takeichi N
Nihon Jibiinkoka Gakkai Kaiho; 1996 Mar; 99(3):385-94. PubMed ID: 8934773
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
